Rocket Companies, Inc. 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed on September 9, 2022, by Rocket Companies, Inc. The filing details material definitive agreements entered into by Rocket Mortgage, LLC, an indirect subsidiary of the registrant, with Citibank, N.A.
Key Financial Metrics and Liquidity
The filing focuses on liquidity facilities rather than operating performance metrics such as revenue or profit.
- Total Funding Capacity: Decreased to $28.85 billion as of September 9, 2022.
- Historical Comparison: Total capacity was $29.6 billion as of June 30, 2022, and $33.5 billion as of March 31, 2022.
- Citi Master Repurchase Agreement (MRA): Facility amount decreased from $2.0 billion to $1.5 billion.
- MSR Facility: Sublimit for mortgage loan servicing financing increased from $1.0 billion to $1.5 billion.
Material Changes Versus Prior Period
The primary material change is the reduction in total funding capacity by $0.75 billion compared to the end of the second quarter ($29.6 billion) and by $4.65 billion compared to the end of the first quarter ($33.5 billion). This reduction is driven by the decrease in the Citi MRA facility size, partially offset by an increase in the MSR facility sublimit.
Management Commentary and Agreements
On September 9, 2022, the Company executed two amendments with Citibank, N.A.:
- MRA Amendment: Extended the expiration date of the Master Repurchase Agreement from September 22, 2023, to September 9, 2024, while reducing the facility size.
- MSR Amendment: Increased the sublimit for MSR financing to $1.5 billion. Proceeds are designated for funding servicer advances or purchases of MSRs, secured by government-sponsored enterprise MSRs.
The filing does not provide specific guidance, risk factors, or unusual items beyond the structural changes to these credit facilities.
Investor Verification Checklist
- Verify the impact of the reduced $1.5 billion MRA facility on the Company's ability to fund mortgage originations.
- Confirm the utilization rates of the increased $1.5 billion MSR facility in upcoming quarterly reports.
- Review the full text of the MSR Amendment in the subsequent Form 10-Q for the period ending September 30, 2022, as referenced in the filing.
- Monitor the trend of total funding capacity, which has declined from $33.5 billion in Q1 2022 to $28.85 billion in Q3 2022.